Indication
Kidney Impairment
2 clinical trials
2 products
Clinical trial
A Phase I Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate the Effect of Severe Kidney Impairment on the Pharmacokinetics, Safety and Tolerability of ZSP1273Status: Recruiting, Estimated PCD: 2024-04-30
Product
ZSP1273Clinical trial
A Phase I Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate the Effect of Severe Kidney Impairment on the Pharmacokinetics, Safety and Tolerability of Leritrelvir(RAY1216)Status: Completed, Estimated PCD: 2023-12-12
Product
Leritrelvir